Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a psychosis-spectrum disorder
- People who are between 18 and 60 years old (inclusive)
- People who are able to read and speak English
- People whose symptoms are considered clinically stable, based on a specific symptom severity score (confirm with trial site)
- People who have not had any changes to their medications — including starting, stopping, or adjusting a dose — in the month before signing the consent form
Who may not be able to join:
- People who have a neurological or medical condition known to affect thinking or memory, including a head injury that caused more than one minute of unconsciousness
- People who have an intellectual disability, or who score 70 or below on a standardised intelligence assessment
- People who have a vision problem that cannot be corrected with glasses or contact lenses that fit inside a virtual reality headset
- People who have a past history of seizures, fits, or epilepsy
- People who have a severe medical condition affecting their eyes, ears, or balance
- People who have had a substance use disorder within the last three months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Synthia Guimond, PhD, Royal Ottawa Mental Health Centre
Phone: 613-722-6521
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of the Intervention (attrition rate).; Feasibility of the intervention (homework completion).; Feasibility of the intervention (cybersickness).; Acceptability of the intervention; Change in the acceptability of the intervention from the sixth intervention visit (3 weeks in intervention) to 1-week post-intervention.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.